Skip to main content
Log in

Estrogen receptor expression in adrenocortical carcinoma

  • Published:
Journal of Zhejiang University SCIENCE B Aims and scope Submit manuscript

Abstract

Objective

Adrenocortical carcinoma (ACC) is a rare but highly malignant tumor, and its diagnosis is mostly delayed and prognosis is poor. We report estrogen receptor (ER) expression in this tumor and our clinical experiences with 17 ACC cases.

Methods

The data of the 17 patients (9 females and 8 males, age range from 16 to 69 years, mean age of 42.6 years) with ACC were reviewed, and symptoms, diagnostic procedures, treatment, and results of follow-up were evaluated. Immunohistochemistry was used to detect ER expression in tumor samples from the 17 patients.

Results

At the time of diagnosis, 4 tumors were classified as Stage I, 4 as Stage II, 3 as Stage III, and 6 as Stage IV. Eight patients demonstrated positive nuclear immunostaining of ER. The prognosis of patients with ER positive was significantly better (P<0.05) than that of patients with ER negative, with 1- and 5-year survival rates at 86% and 60% for ER-positive patients, and 38% and 0% for ER-negative patients, respectively.

Conclusion

ER-positivity may be one of the factors associated with a worse prognosis of ACC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Allolio, B., Fassnacht, M., 2006. Adrenocortical carcinoma: clinical update. J. Clin. Endocrinol. Metab., 91(6):2027–2037. [doi:10.1210/jc.2005-2639]

    Article  PubMed  CAS  Google Scholar 

  • Chen, D.Y., Sosa, R.E., Scherr, D.S., 2004. Treatment of adrenocortical carcinoma: contemporary outcomes. Current Urology Reports, 5(1):65–72. [doi:10.1007/s11934-004-0014-x]

    Article  PubMed  Google Scholar 

  • Colletti, R.B., Roberts, J.D., Devlin, J.T., Copeland, K.C., 1989. Effects of tamoxifen on insulin-like growth factor 1 in patients with breast cancer. Cancer Res., 49(7):1882–1884.

    PubMed  CAS  Google Scholar 

  • Dackiw, A.P., Lee, J.E., Gagel, R.F., Evans, D.B., 2001. Adrenal cortical carcinoma. World J. Surg., 25(7):914–926. [doi:10.1007/s00268-001-0030-7]

    Article  PubMed  CAS  Google Scholar 

  • Demeure, M.J., Somberg, L.B., 1998. Functioning and nonfunctioning adrenocortical carcinoma: clinical presentation and therapeutic strategies. Surg. Oncol. Clin. N. Am., 7(4):791–805.

    PubMed  CAS  Google Scholar 

  • Dickson, R.B., Lippman, M.E., 1987. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr. Rev., 8(1):29–43.

    Article  PubMed  CAS  Google Scholar 

  • Lingappa, V.R., Farey, K., 2001. Physiological Medicine: A Clinical Approach to Basic Medical Physiology. McGraw-Hill, p.584.

  • MacFarlane, D.A., 1958. Cancer of the adrenal cortex: the natural history, prognosis and treatment in the study of fifty-five cases. Ann. R. Coll. Surg. Engl., 23(3):155–186.

    PubMed  CAS  Google Scholar 

  • Medeiros, L.J., Weiss, L.M., 1991. New development in the pathologic diagnosis of adrenal cortical neoplasms: a review. Am. J. Clin. Pathol., 97(1):73–83.

    Google Scholar 

  • Ng, L., Libertino, J.M., 2003. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J. Urol., 169(1):5–11. [doi:10.1016/S0022-5347(05)64023-2]

    Article  PubMed  Google Scholar 

  • Osborne, C.K., Boldt, D.H., Clark, G.M., Trent, J.M., 1983. Effects of tamoxifen on human breast cancer cell kinetics: accumulation of cells in early G1 phase. Cancer Res., 43(8):3583–3585.

    PubMed  CAS  Google Scholar 

  • Pommier, R.F., Brennan, M.F., 1992. An eleven-year experience with adrenocortical carcinoma. Surgery, 112(6):963–970.

    PubMed  CAS  Google Scholar 

  • Schteingart, D.E., Doherty, G.M., GAuger, P.G., Giordano, T.J., Hammer, G.D., Korobkin, M., Worden, F.P., 2005. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr. Relat. Cancer, 12(3):667–680. [doi:10.1677/erc.1.01029]

    Article  PubMed  CAS  Google Scholar 

  • Schulick, R.D., Brennan, M.F., 1999. Adrenocortical carcinoma. World J. Urol., 17(1):26–34. [doi:10.1007/s003450050101]

    Article  PubMed  CAS  Google Scholar 

  • Sullivan, M., 1978. Adrenal cortical carcinoma. Urology, 120(6):660–665.

    CAS  Google Scholar 

  • Weiss, L.M., 1984. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am. J. Surg. Pathol., 8(3):163.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yi-qing Qiu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shen, Xc., Gu, Cx., Qiu, Yq. et al. Estrogen receptor expression in adrenocortical carcinoma. J. Zhejiang Univ. Sci. B 10, 1–6 (2009). https://doi.org/10.1631/jzus.B0820072

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1631/jzus.B0820072

Key words

CLC number

Navigation